| Financial Year |
March 31 2023 |
| Monetary Funds |
277,337,472.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
382,400.00 |
| Accounts Receivable |
141,462,501.21 |
| Advances to Suppliers |
17,948,094.02 |
| Other Receivables |
15,214,411.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
209,249,146.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,939,264.31 |
| Total Current Assets |
713,484,061.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,911,474,742.60 |
| Investment Properties |
664,510,723.17 |
| Fixed Assetes |
494,147,424.07 |
| Under-construction Projects |
75,665,960.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,787,607.60 |
| R&D expenses |
-- |
| Goodwill |
47,311,552.61 |
| Long-Term Deferred and Prepaid Expenses |
45,514,314.27 |
| Deferred Income Tax Assets |
64,379,541.94 |
| Other Non-Current Assets |
1,878,874.50 |
| Sub-Total of Non-Current Assets |
3,406,899,522.05 |
| Total Assets |
4,120,383,583.10 |
| Short-Term Loans |
214,750,812.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
185,673,486.55 |
| Accounts Received In Advance |
10,476,395.29 |
| Employee Compensation Payable |
5,584,543.37 |
| Taxes Payable |
4,974,525.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,389,342.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,388,232.80 |
| Other Current Liabilities |
1,494,629.52 |
| Sub-Total of Current Liabilities |
489,766,047.09 |
| Long-term Loans |
230,313,333.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,669,563.27 |
| Deferred Income Tax Liabilities |
21,316,638.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
308,034,967.01 |
| Total Liabilities |
797,801,014.10 |
| Paid-In Capital(Or Share Stock) |
580,348,513.00 |
| Capital Surplus |
2,904,955,341.12 |
| Surplus Reserve |
109,397,557.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-340,925,303.49 |
| Minority Stockholder's Interest |
68,806,460.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,253,776,108.06 |
| Owner's Equity（Stockholder's Equity） |
3,322,582,569.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,120,383,583.10 |
